The Unraveling: Cardiac and Musculoskeletal Defects and Their Role in Common Alzheimer Disease Morbidity and

Vidyani Suryadevara1, Michael Klüppel1, Federica Del Monte2

  • 1Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, Indiana.

Insights

Alzheimer disease (AD) affects the heart and muscles, causing issues like heart failure and muscle weakness. This systemic disease impacts bone density, increasing fall risks and highlighting the need for new therapeutic strategies.

Area of Science:

  • Neurology
  • Cardiology
  • Musculoskeletal Medicine

Background:

  • Alzheimer disease (AD) affects millions globally, primarily known for cognitive decline.
  • Common co-morbidities include heart failure and musculoskeletal deficits, but their link to AD pathophysiology is unclear.

Purpose of the Study:

  • This review is the first to consolidate findings on cardiac and musculoskeletal deficits in human AD.
  • To explore the systemic nature of AD and its potential impact on multiple organ systems.

Main Methods:

  • Review of recent clinical studies on cardiac and musculoskeletal conditions in AD patients.
  • Inclusion of animal model data for underlying bone and muscle mechanisms.

Main Results:

  • AD hearts show diastolic heart failure, amyloid deposits, and electrophysiological changes.
  • Musculoskeletal issues include primary muscle weakness (without mass loss) in mild cognitive impairment, progressing to atrophy in AD.
  • Bone density loss is observed in AD patients, correlating with increased fracture and fall risk.

Conclusions:

  • Alzheimer disease presents as a systemic illness affecting cardiac and musculoskeletal systems.
  • Understanding these deficits may offer new therapeutic targets, diagnostic biomarkers, and insights into AD pathogenesis.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
682
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
443
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
327